Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tongchuanqing granules for pediatric asthma
CTR20132724Phase 3Active
- Sponsor
- Nanjing Kailai Pharmaceutical Technology Development
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Tongchuanqing Granule in asthma, sponsored by Nanjing Kailai Pharmaceutical Technology Development. Started Jan 2014; status: active.
02
Drugs
Tongchuanqing Granule
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20132724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132724.